Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.74 -9.63 (-3.08%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Interest Expenses (2010 - 2026)

Updated

Ligand Pharmaceuticals' Interest Expenses came in at $1.75 million for Q2 2026, up 51.6% from $1.15 million a year earlier and up 0.1% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Interest Expenses (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Ligand Pharmaceuticals reported Interest Expenses of $6.19 million, up 69.9% year-over-year; for FY2025, it was $4.72 million, up 55.3% from FY2024.

  • Interest Expenses carries a five-year compound annual growth rate of -29.7% (FY2020 to FY2025).
  • Going back by year, Interest Expenses was $3.04 million in FY2024 (+363.0%), $656,000 in FY2023 (-63.5%), $1.8 million in FY2022 (-90.8%) and $19.62 million in FY2021 (-28.4%).
  • The five-year range for quarterly Interest Expenses is $1,000 (Q3 2023) to $4.47 million (Q4 2021).
  • Year-over-year, Interest Expenses has increased for four consecutive quarters, with growth averaging 194.0% over the last seven quarters.
  • The fastest year-over-year change in Interest Expenses over five years came in Q4 2024 (growth of 574.0%), and the weakest in Q3 2023 (a decline of 99.7%).
  • Business Quant data shows LGND's Interest Expenses at $1.75 million (Q1 2026), $1.79 million (Q4 2025) and $910,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ligand Pharmaceuticals 6.22 Bn 2.69 Bn - 1.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.75 Mn
Mar 31, 2026 1.75 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 910,000.00
Jun 30, 2025 1.15 Mn
Mar 31, 2025 867,000.00
Dec 31, 2024 883,000.00
Sep 30, 2024 741,000.00
Jun 30, 2024 1.27 Mn
Mar 31, 2024 141,000.00
Dec 31, 2023 131,000.00
Sep 30, 2023 1,000.00
Jun 30, 2023 284,000.00
Mar 31, 2023 240,000.00
Dec 31, 2022 240,000.00
Sep 30, 2022 332,000.00
Jun 30, 2022 438,000.00
Mar 31, 2022 789,000.00
Dec 31, 2021 4.47 Mn
Sep 30, 2021 4.44 Mn
API Access

Ligand Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=LGND&period=max&api_key=YOUR_API_KEY